The effect of chemotherapy on telomere dynamics: clinical results and possible mechanisms

References

• Mauch P, Constine L, Greenberger J, et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys 1995;31:1319–1339.
   PubMed Web of Science ®Google Scholar
• Lerner C, Harrison DE. 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp Hematol 1990;18:114–118.
   PubMed Web of Science ®Google Scholar
• Hodgson GS, Bradley TR. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment:evidence for a pre-CFU-S cell?. Nature 1979;281:381–382.
   PubMed Web of Science ®Google Scholar
• Berger MG, Berger J, Richard C, et al. Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization. Leukemia 2008;22:2131–2134.
   PubMed Web of Science ®Google Scholar
• Nervi B, Link DC, DiPersio JF. Cytokines and hematopoietic stem cell mobilization. J Cell Biochem 2006;99:690–705.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Sun CL, Francisco L, et al. Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma. J Clin Oncol 2009;27:791–798.
   PubMed Web of Science ®Google Scholar
• Watson JD. Origin of concatemeric T7 DNA. Nat New Biol 1972; 239:197–201.
   PubMedGoogle Scholar
• Schwartz HS, Dahir GA, Butler MG. Telomere reduction in giant cell tumor of bone and with aging. Cancer Genet Cytogenet 1993;71:132–138.
   PubMed Web of Science ®Google Scholar
• Hastie ND, Dempster M, Dunlop MG, et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866–868.
   PubMed Web of Science ®Google Scholar
• Vaziri H, Schächter F, Uchida I, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993;52:661–667.
   PubMed Web of Science ®Google Scholar
• Butler MG, Tilburt J, DeVries A, et al. Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages. Cancer Genet Cytogenet 1998;105:138–144.
   PubMed Web of Science ®Google Scholar
• Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405–413.
   PubMed Web of Science ®Google Scholar
• Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011–2015.
   PubMed Web of Science ®Google Scholar
• Kolquist KA, Ellisen LW, Counter CM, et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 1998;19:182–186.
   PubMed Web of Science ®Google Scholar
• Vaziri H, Dragowska W, Allsopp RC, et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994;91:9857–9860.
   PubMed Web of Science ®Google Scholar
• Van Ziffle JA, Baerlocher GM, Lansdorp PM. Telomere length in subpopulations of human hematopoietic cells. Stem Cells 2003; 21:654–660.
   PubMed Web of Science ®Google Scholar
• Wynn RF, Cross MA, Hatton C, et al. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 1998;351:178–181.
   PubMed Web of Science ®Google Scholar
• Rufer N, Brümmendorf TH, Chapuis B, et al. Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood 2001;97:575–577.
   PubMed Web of Science ®Google Scholar
• Robertson JD, Testa NG, Russell NH, et al. Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant. Bone Marrow Transplant 2001;27:1283–1286.
   PubMed Web of Science ®Google Scholar
• de Pauw ES, Otto SA, Wijnen JT, et al. Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion. Br J Haematol 2002;116:491–496.
   PubMed Web of Science ®Google Scholar
• Lahav M, Uziel O, Kestenbaum M, et al. Nonmyeloablative conditioning does not prevent telomere shortening after allogeneic stem cell transplantation. Transplantation 2005;80:969–976.
   PubMed Web of Science ®Google Scholar
• Akiyama M, Asai O, Kuraishi Y, et al. Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2000;25:441–447.
   Google Scholar
• Engelhardt M, Ozkaynak MF, Drullinsky P, et al. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia 1998;12:13–24.
   PubMed Web of Science ®Google Scholar
• Franco S, Ozkaynak MF, Sandoval C, et al. Telomere dynamics in childhood leukemia and solid tumors: a follow-up study. Leukemia 2003;17:401–410.
   PubMed Web of Science ®Google Scholar
• Szyper-Kravitz M, Uziel O, Shapiro H, et al. Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34 + haematopoietic cells and may prevent telomere attrition after chemotherapy. Br J Haematol 2003;120:329–336.
   PubMed Web of Science ®Google Scholar
• Lee JJ, Nam CE, Cho SH, et al. Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy. Ann Hematol 2003;82:492–495.
   PubMed Web of Science ®Google Scholar
• Unryn BM, Hao D, Glück S, et al. Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer. Clin Cancer Res 2006;12:6345–6350.
   PubMed Web of Science ®Google Scholar
• Yoon SY, Sung HJ, Park KH, et al. Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity. Acta Haematol 2007;118:30–37.
   PubMed Web of Science ®Google Scholar
• Schröder CP, Wisman GB, de Jong S, et al. Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br J Cancer 2001;84:1348–1353.
   PubMed Web of Science ®Google Scholar
• Stewart FM, Temeles D, Lowry P, et al. Post-5-fluorouracil human marrow: stem cell characteristics and renewal properties after autologous marrow transplantation. Blood 1993;81:2283–2289.
   PubMed Web of Science ®Google Scholar
• Visani G, Lemoli RM, Tosi P, et al. Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients. Br J Haematol 1999;105:775–779.
   PubMed Web of Science ®Google Scholar
• Sakoff JA, De Waal E, Garg MB, et al. Telomere length in haemopoietic stem cells can be determined from that of mononuclear blood cells or whole blood. Leuk Lymphoma 2002;43:2017–2020.
   PubMed Web of Science ®Google Scholar
• Rufer ND, Thornbury G, Roosnek E, et al. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 1998;16:743–747.
   PubMed Web of Science ®Google Scholar
• Asai A, Kiyozuka Y, Yoshida R, et al. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs. Anticancer Res 1998;18:1465–1472.
   PubMed Web of Science ®Google Scholar
• Roelofs H, de Pauw ES, Zwinderman AH, et al. Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation. Blood 2003;101:358–362.
   PubMed Web of Science ®Google Scholar